Publication | Closed Access

Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin

Tumor BiologyOncologyMedicineSmall Molecule InhibitorAnti-cancer AgentCell BiologyTumor SuppressorCucurbitacin BCancer BiologyRadiation OncologyCell SignalingCancer ResearchCancer Growth